Add Company
Join Now

coIMMUNE Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • coIMMUNE's estimated annual revenue is currently $3.7M per year.(i)
  • coIMMUNE's estimated revenue per employee is $77,520

Employee Data

  • coIMMUNE has 48 Employees.(i)
  • coIMMUNE grew their employee count by -2% last year.

coIMMUNE's People

NameTitleEmail/Phone
1
Staff ScientistReveal Email/Phone
2
CQV Specialist IIReveal Email/Phone
3
Stability Program CoordinatorReveal Email/Phone
4
Quality Associate IIReveal Email/Phone
5
QC Stability CoordinatorReveal Email/Phone
6
Associate ResearcherReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.4M420%N/AN/A
#2
$928.5M65020%N/AN/A
#3
$19.6M175-1%N/AN/A
#4
$5.4M688%N/AN/A
#5
$0.6M10-33%N/AN/A
#6
$19.4M17711%$1.8MN/A
#7
$3.1M380%N/AN/A
#8
$17.6M1578%N/AN/A
#9
$21.4M17735%N/AN/A
#10
$11.3M10310%N/AN/A
Add Company

What Is coIMMUNE?

CoImmune Inc. is a US company based in Durham North Carolina that was founded in 2019 based on its expertise in the development and manufacture of cell-based therapeutics to treat unmet medical needs including cancer, autoimmune and inflammatory diseases.

keywords:N/A

N/A

Total Funding

48

Number of Employees

$3.7M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

coIMMUNE News

2020-11-10 - CoImmune Closes $45 Million Series A Financing

DURHAM, N.C., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CoImmune, Inc., an immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the closing of a $45M Series A financing. CoImmune will use the proceeds from the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.3M48-20%$2.8M
#2
$6.9M484%N/A
#3
$7.5M48-2%N/A
#4
$12.9M4940%N/A
#5
$10.6M497%N/A